Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO ...

2025 年 10 月 9 日，美股生物技术板块迎来重磅交易 —— 全球制药巨头诺和诺德宣布以最高 52 亿美元总价收购美国生物制药公司 Akero Therapeutics(AKRO.US)，旨在将后者旗下前景广阔的肝病候选药物 efruxifermin 纳入囊中。受此利好推动，Akero Therapeutics 股价当日盘中大涨 ...

We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. Akero Therapeutics, Inc. (NASDAQ:AKRO) is one of the best performers on Thursday. Akero Therapeutics saw its share prices ...

Fintel reports that on October 10, 2025, Wolfe Research downgraded their outlook for Akero Therapeutics (NasdaqGS:AKRO) from Outperform to Peer Perform. Analyst Price Forecast Suggests 40.09% Upside ...

Columbus Day, also known as Indigenous Peoples’ Day, is a federal holiday observed on the second Monday of October. Federal offices, banks, and post offices will be closed, with only USPS Priority ...

智通财经APP获悉，丹麦制药巨头诺和诺德(NVO.US)周四宣布已达成最终协议，将收购美国生物制药公司Akero Therapeutics(AKRO.US)，交易总价最高达52亿美元。根据协议条款，诺和诺德将以每股54美元、总价47亿美元现金收购Akero，并附带每股6美元不可转让的“或有价值权 ...

丹麦制药巨头诺和诺德(NVO.US)周四宣布已达成最终协议，将收购美国生物制药公司Akero Therapeutics(AKRO.US)，交易总价最高达52亿美元。根据协议条款，诺和诺德将以每股54美元、总价47亿美元现金收购Akero，并附带每股6美元不可转让的“或有价值权” (CVR)——这一 ...

Akero Therapeutics saw its share prices jump by 16.33 percent on Thursday to end at $54.08 apiece following announcements that it was set to merge with Novo Nordisk in a $5.2 billion deal. In a ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akero Therapeutics, Inc. (NASDAQ: AKRO) to Novo Nordisk A/S is fair to Akero shareholders. Under the terms of the ...